Discontinuing prophylaxis against recurrent opportunistic infections in HIV-infected persons: A victory in the era of HAART

Annals of Internal Medicine

Volumn 137, Issue 4, 2002, Pages 285-287

  Kaplan, Jonathan E ^a   Masur, Henry ^a   Holmes, King K ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIRETROVIRUS AGENT;

CHEMOPROPHYLAXIS; CRYPTOCOCCOSIS; CYTOMEGALOVIRUS INFECTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LYMPHOCYTE COUNT; MAINTENANCE THERAPY; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS PNEUMONIA; PRIMARY PREVENTION; PRIORITY JOURNAL; RECURRENT INFECTION; SECONDARY PREVENTION; SHORT SURVEY; TOXOPLASMOSIS;

EID: 0037143528     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-137-4-200208200-00013     Document Type: Short Survey

References (15)

1. Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy
2. Discontinuation of prophylaxis for Mycobacterium avium complex disease in HIV-infected patients who have a response to antiretroviral therapy. Terry Beirn Community Programs for Clinical Research on AIDS
3. Stopping primary prophylaxis in HIV-1-infected patients at high risk of toxoplasma encephalitis
4. Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy
5. Guidelines for preventing opportunistic infections among HIV-infected persons - 2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America
6. Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy
7. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis
8. Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients
9. Eradication of AIDS-related disseminated Mycobacterium avium complex infection after 12 months of antimycobacterial therapy combined with highly active antiretroviral therapy
10. Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapy
11. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: The Swiss HIV Cohort Study
12. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease
13. Joint effects of HIV-1 RNA levels and CD4 lymphocyte cells on the risk of specific opportunistic infections
14. Viral load as an independent risk factor for opportunistic infections in HIV-infected adults and adolescents
15. Loss of cytomegalovirus-specific CD4 T cell responses in human immunodeficiency virus type 1-infected patients with high CD4 T cell counts and recurrent retinitis